tiprankstipranks
Trending News
More News >
Jiutian Chemical Group Limited (SG:C8R)
SGX:C8R
Singapore Market

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

Compare
7 Followers

Top Page

SG

Jiutian Chemical Group Limited

(SGX:C8R)

Rating:38Underperform
Price Target:
S$0.00
▼(-100.00%Downside)
The overall stock score is significantly impacted by the company's poor financial performance, negative technical indicators, and unattractive valuation. The severe decline in revenue and profitability, combined with negative cash flow and poor market momentum, presents substantial risks. These factors underscore the challenges facing Jiutian Chemical Group Limited, making it a highly risky investment.

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company DescriptionJiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol. In addition, the company is involved in the sale of downstream products; and research and development of isotope technology. Jiutian Chemical Group Limited was founded in 1994 and is based in Singapore.
How the Company Makes MoneyJiutian Chemical Group Limited generates revenue through the manufacturing and sale of chemical products, specifically dimethylformamide (DMF) and methylamine. These products are used as solvents and intermediates in various industrial processes, providing essential components for the production of pharmaceuticals, agrochemicals, and other industrial goods. The company's revenue streams are primarily driven by sales contracts with manufacturers in these sectors. Additionally, Jiutian Chemical may benefit from strategic partnerships and long-term supply agreements that ensure stable demand and consistent income. By leveraging its production capabilities and focusing on high-quality chemical manufacturing, the company maintains a competitive position in the global chemical market.

Jiutian Chemical Group Limited Financial Statement Overview

Summary
Jiutian Chemical Group Limited is facing severe financial difficulties, with declining revenue, profitability, and cash flow. The income statement shows critical weaknesses in generating profits, while the balance sheet indicates moderate leverage but declining equity. Cash flow challenges further exacerbate the company's financial instability, raising concerns about its ability to sustain operations.
Income Statement
15
Very Negative
Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over the past years. The gross profit margin and net profit margin have turned negative, indicating that the company is not covering its costs. The revenue growth rate has decreased significantly, with a notable drop in total revenue from 2022 to 2023. EBIT and EBITDA margins are also negative, highlighting poor operational performance. Overall, the company's income statement presents substantial financial challenges.
Balance Sheet
40
Negative
The balance sheet of Jiutian Chemical Group Limited shows moderate leverage with a debt-to-equity ratio that has improved slightly over the years. However, the equity ratio has decreased, indicating a decline in the proportion of assets financed by equity. Return on Equity (ROE) has become negative due to consecutive net losses. Although cash reserves are relatively strong, the overall stability is compromised by declining equity and profitability.
Cash Flow
20
Very Negative
The cash flow situation is concerning, with free cash flow experiencing a negative growth rate and operating cash flow consistently negative over the recent years. The operating cash flow to net income ratio is unfavorable, reflecting inefficiencies in converting income to cash. Free cash flow to net income ratio is also negative, indicating cash flow issues that could impact future operations.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
393.13M243.76M598.56M2.43B2.17B1.15B
Gross Profit
-147.20M-82.26M-260.18M708.41M675.62M274.77M
EBIT
-166.58M-112.51M-309.23M680.84M603.40M233.46M
EBITDA
-141.98M-118.22M-321.76M696.61M632.38M259.93M
Net Income Common Stockholders
-162.31M-147.80M-344.64M490.50M324.90M173.69M
Balance SheetCash, Cash Equivalents and Short-Term Investments
698.48M400.41M529.62M1.11B773.55M259.73M
Total Assets
1.42B1.05B1.29B1.99B1.89B1.43B
Total Debt
234.88M289.32M265.88M134.64M228.18M344.30M
Net Debt
-463.59M-111.10M-263.74M-972.98M-545.37M84.57M
Total Liabilities
469.16M427.02M523.23M764.65M1.08B911.93M
Stockholders Equity
948.17M618.04M765.84M1.22B816.21M524.74M
Cash FlowFree Cash Flow
-356.18M-171.63M-511.23M424.05M633.54M122.69M
Operating Cash Flow
-328.39M-81.58M-385.65M434.01M655.81M129.02M
Investing Cash Flow
-27.72M-89.54M-125.70M-9.85M-27.68M-10.90M
Financing Cash Flow
-53.04M32.87M-732.00K-95.52M-110.89M5.67M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.03
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
0.05
Positive
STOCH
-66.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 0.05 is Positive, neither overbought nor oversold. The STOCH value of -66.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$2.04B-1.21-21.10%3.95%2.90%-30.45%
SGC8R
38
Underperform
S$47.72M-21.30%-60.43%57.93%
SGC05
S$39.49M5.85-17.75%2.88%
SG5DS
S$55.99M7.0814.57%1.19%
SGA55
S$51.36M126.360.37%3.60%
SGBEI
S$55.37M24.883.88%4.81%
SGY8E
S$32.12M-10.42%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-33.33%
SG:C05
Chemical Industries Far East Ltd.
0.52
-0.03
-5.45%
SG:5DS
MegaChem Ltd.
0.42
-0.04
-8.70%
SG:A55
Asia Enterprises Holding Ltd.
0.14
0.01
7.69%
SG:BEI
LHT Holdings Ltd
1.04
0.00
0.00%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.10
0.02
25.00%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Group Holds Twentieth AGM
May 19, 2025

Jiutian Chemical Group Limited held its Twentieth Annual General Meeting at Voco Orchard Singapore, where the Board of Directors and key company officials were present. The meeting was chaired by Executive Director Mr. Lee Chee Seng and addressed shareholder questions regarding resolutions, with responses published on SGXNet prior to the meeting.

Jiutian Chemical Reports Revenue Decline Amid Market Challenges
Apr 25, 2025

Jiutian Chemical Group Limited reported a significant decline in revenue for the first quarter of 2025, with an 83% drop compared to the same period last year, due to weak demand and increased competition. Despite this, the company managed to reduce its net loss by 56% through effective cost control and streamlined operations, reflecting a strategic focus on long-term efficiency and competitiveness.

Jiutian Chemical Group Publishes Shareholder Q&A Ahead of AGM
Apr 17, 2025

Jiutian Chemical Group Limited has announced that it has published responses to shareholder questions ahead of its 20th Annual General Meeting. This move aims to enhance transparency and engage with shareholders effectively, potentially strengthening stakeholder relations and reinforcing the company’s commitment to open communication.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.